Mike Stratton, President of CSSi, an Elixia company, discusses best practices for building trust and transparency with clinical trial participants. Mike shares the impact of trust-building initiatives and patient-centric communication on retention, medication adherence, and overall trial success. Tune in to hear how CSSi is reshaping patient engagement—ensuring participants feel valued, informed, and supported every step of the way.